19 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 28333940 | Distinct transcriptome profiles of Gag-specific CD8+ T cells temporally correlated with the protection elicited by SIVĪnef live attenuated vaccine. | 2017 | 1 |
2 | 27091995 | Structural basis for oligomerization and glycosaminoglycan binding of CCL5 and CCL3. | 2016 May 3 | 4 |
3 | 19068144 | Dose dependent effects of platelet derived chondroitinsulfate A on the binding of CCL5 to endothelial cells. | 2008 Dec 10 | 2 |
4 | 18025279 | Glycosaminoglycans and their synthetic mimetics inhibit RANTES-induced migration and invasion of human hepatoma cells. | 2007 Nov | 10 |
5 | 16807236 | CCL5-CCR5-mediated apoptosis in T cells: Requirement for glycosaminoglycan binding and CCL5 aggregation. | 2006 Sep 1 | 6 |
6 | 15355933 | RANTES (CCL5) induces a CCR5-dependent accelerated shedding of syndecan-1 (CD138) and syndecan-4 from HeLa cells and forms complexes with the shed ectodomains of these proteoglycans as well as with those of CD44. | 2005 Feb | 1 |
7 | 15686348 | Site-specific polymer attachment to a CCL-5 (RANTES) analogue by oxime exchange. | 2005 Feb 9 | 2 |
8 | 12763925 | Oligomerization of RANTES is required for CCR1-mediated arrest but not CCR5-mediated transmigration of leukocytes on inflamed endothelium. | 2003 Sep 15 | 3 |
9 | 12773479 | Binding of the CC-chemokine RANTES to syndecan-1 and syndecan-4 expressed on HeLa cells. | 2003 Sep | 3 |
10 | 12847218 | A high endothelial venule secretory protein, mac25/angiomodulin, interacts with multiple high endothelial venule-associated molecules including chemokines. | 2003 Jul 15 | 2 |
11 | 14637022 | Interaction of RANTES with syndecan-1 and syndecan-4 expressed by human primary macrophages. | 2003 Oct 31 | 1 |
12 | 11836402 | Interaction of the CC-chemokine RANTES with glycosaminoglycans activates a p44/p42 mitogen-activated protein kinase-dependent signaling pathway and enhances human immunodeficiency virus type 1 infectivity. | 2002 Mar | 2 |
13 | 10766793 | Examination of the function of RANTES, MIP-1alpha, and MIP-1beta following interaction with heparin-like glycosaminoglycans. | 2000 Apr 21 | 1 |
14 | 10917892 | RANTES activates antigen-specific cytotoxic T lymphocytes in a mitogen-like manner through cell surface aggregation. | 2000 Aug | 2 |
15 | 9891023 | Generation of artificial proteoglycans containing glycosaminoglycan-modified CD44. Demonstration of the interaction between rantes and chondroitin sulfate. | 1999 Jan 22 | 1 |
16 | 10504268 | Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. | 1999 Sep 28 | 2 |
17 | 10588734 | Soluble complexes of regulated upon activation, normal T cells expressed and secreted (RANTES) and glycosaminoglycans suppress HIV-1 infection but do not induce Ca(2+) signaling. | 1999 Dec 7 | 1 |
18 | 9815269 | A new monoclonal antibody, mAb 4A12, identifies a role for the glycosaminoglycan (GAG) binding domain of RANTES in the antiviral effect against HIV-1 and intracellular Ca2+ signaling. | 1998 Nov 16 | 3 |
19 | 9354625 | Glycosaminoglycans mediate cell surface oligomerization of chemokines. | 1997 Nov 4 | 2 |